Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New York Botanical Garden (NYBG) is a preeminent center for plant research and conservation, operating one of the world's most extensive botanical science programs. Through its Institute of Economic Botany and the Cullman Program for Molecular Systematics, NYBG conducts foundational research in ethnobotany and plant genomics that supports drug discovery and natural product development. The institution houses the Pfizer Plant Research Laboratory, a state-of-the-art facility dedicated to molecular biology and genomics research. NYBG's scientists work globally to document plant diversity and investigate the chemical properties of plants used in traditional medicine. This research provides critical data and source material for the identification of novel therapeutic compounds in areas such as oncology and infectious diseases. The institution plays a vital role in the global effort to preserve plant life essential for future medical breakthroughs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The New York Botanical Garden.